Etentamig
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Etentamig, covering 2025-12-17 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant [Phase 2, Phase 3]